Bruce K. Dallas
Lawyers
Filters
Davis Polk Advises Texas Instruments on Its $1.3 Billion Notes Offering
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $1.3 billion aggregate principal amount of 4.150% notes due 2048.
Texas Instruments is a global…
Davis Polk Advises Comcast on Its £22 Billion Cash Offer for Sky
Davis Polk is advising Comcast Corporation in connection with its £22 billion ($30 billion) pre-conditional cash offer to acquire the entire share capital of Sky plc. Under the terms of…
Aeglea BioTherapeutics $36 Million Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $36 million SEC-registered common stock offering by Aeglea BioTherapeutics, Inc. The common stock is listed on…
Xencor, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $226.3 million public offering of common stock of Xencor, Inc. The common stock is listed on the NASDAQ Global…
Corvus Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $69 million SEC-registered common stock offering by Corvus Pharmaceuticals, Inc. The common stock is listed on the…
Atara Biotherapeutics, Inc. Follow-On Offerings
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with two SEC-registered follow-on offerings of common stock of Atara…
Davis Polk Advises Comcast Corporation on Its $800 Million Offering in Taiwan
Davis Polk advised Comcast Corporation in connection with an SEC-registered offering in Taiwan of $800 million aggregate principal amount of 4.250% notes due 2053. The notes are listed on…
Davis Polk Advises Comcast Corporation on Its $3.2 Billion Notes Offering
Davis Polk advised Comcast Corporation on its $3.2 billion SEC-registered debt offering of 3.550% notes due 2028, 3.900% notes due 2038 and 4.000% notes due 2048.
Comcast is a global…
Adamas Pharmaceuticals, Inc. Common Stock Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $124.5 million SEC-registered follow-on offering of 3,000,000 shares of common stock of Adamas Pharmaceuticals, Inc…
BeiGene, Ltd. $800 Million Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $800 million public offering by BeiGene, Ltd. of American depositary shares. The ADSs are…